These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 399243

  • 21. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL, Jones RN, Thornsberry C.
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [Abstract] [Full Text] [Related]

  • 22. Comparative activity of cefixime and cefaclor in an in vitro model simulating human pharmacokinetics.
    Nies BA.
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):558-61. PubMed ID: 2504600
    [Abstract] [Full Text] [Related]

  • 23. [Subinhibitory activity of cefaclor and cephalexin (author's transl)].
    Shah PM, Staszewski S.
    Infection; 1979 Jun; 7 Suppl 6():543-6. PubMed ID: 399246
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
    Simon C.
    Infection; 1987 Jun; 15(2):122-4. PubMed ID: 3596808
    [Abstract] [Full Text] [Related]

  • 25. [Bacteriological in vitro investigations with cefaclor. Correlation of inhibition zone diameter and minimal inhibitory concentration (author's transl)].
    Grimm H.
    Infection; 1979 Jun; 7 Suppl 6():540-2. PubMed ID: 399245
    [Abstract] [Full Text] [Related]

  • 26. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL, Schoenknect FD, Shadomy S, Sherris JC, Thornsberry C, Washington JA, Kammer RB.
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [In vitro activity of oral cephalosporins (author's transl)].
    Wiedemann B, Flensberg T.
    Infection; 1979 Nov; 7 Suppl 6():551-3. PubMed ID: 399247
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Resistance to gentamicin: a growing concern.
    Siebert WT, Moreland NJ, Williams TW.
    South Med J; 1977 Mar; 70(3):289-92. PubMed ID: 322294
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.
    Santoro J, Levison ME.
    Antimicrob Agents Chemother; 1977 Sep; 12(3):442-3. PubMed ID: 907337
    [Abstract] [Full Text] [Related]

  • 37. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B, Kayser FH.
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II.
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [Abstract] [Full Text] [Related]

  • 40. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM, Gebicka K, Borowski J.
    J Hyg Epidemiol Microbiol Immunol; 1973 May; 17(2):129-40. PubMed ID: 4199760
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.